Shilo V. Lefresne
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
A Response to the Letter to the Editor.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 01, 2026
Environmental sustainability in palliative care: a narrative review.
Journal: Annals of palliative medicine
Published: December 15, 2025
Osimertinib and Stereotactic Radiosurgery for Brain Metastases in EGFR-Mutated Lung Cancer: The STARLET Joint Analysis of OUTRUN and LUOSICNS Randomized Trials.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 17, 2025
RAPid simPLE (RAPPLE) Targeted Radiation Treatment Versus Whole Brain Radiation Therapy: A Retrospective Cohort Study of Matched Patients With Brain Metastases and Poor Prognosis.
Journal: Advances in radiation oncology
Published: July 15, 2025
Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiation Therapy for Oligometastatic Disease: A Secondary Analysis of the Phase 2 SABR-5 Trial.
Journal: International journal of radiation oncology, biology, physics
Published: October 16, 2024
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial.
Journal: International journal of radiation oncology, biology, physics
Published: March 28, 2024
Exploring the value of structured narrative feedback within the Serious Illness Conversation-Evaluation Exercise (SIC-Ex): a qualitative analysis.
Journal: BMJ open
Published: January 29, 2024
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.
Journal: BMC cancer
Published: December 18, 2023
Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II Trial.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: September 13, 2023
Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II Trial.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: September 11, 2023
Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 Trial.
Journal: International journal of radiation oncology, biology, physics
Published: August 07, 2023
Last Updated: 09/26/2026